Categories

Archives

Recent Posts

  • More Pulmonary Fibrosis News

    Here’s an interesting article from a few days ago:

    Adult Stem Cells Migrate to Lung, Contribute to Pulmonary Fibrosis

    09 Aug 2004

    UCLA researchers for the first time identified and then stopped a type of adult stem cell from migrating to the lung and contributing to pulmonary fibrosis in an animal model. Pulmonary fibrosis (i.e, idiopathic pulmonary fibrosis) in humans is a devastating terminal disorder that causes an overabundance of scar tissue to form in the lung.

    IMPACT: The new study may offer novel therapies to treat idiopathic pulmonary fibrosis– currently there are no effective treatments and the mortality rate is approximately 70 percent within five years of diagnosis. Over 80,000 individuals in the United States suffer from the disease. [medicalnewstoday.com]

  • Medbloggers

    Jon Udell has a great post on Medbloggers, something that I didn’t really realize existed until he wrote about it. Though we’ve got political bloggers, library bloggers, law bloggers, so it makes sense there would be medical bloggers.

    Medbloggers

    The numbers are small. Starting with Pho’s blogroll, I began assembling a list of the medical bloggers who cross-reference one another. What I found confirmed Pho’s estimate that there are no more than 100 of these medbloggers, many of whom are aggregated at medlogs.com. Nor are these medblogs yet widely subscribed. Pho today has 14 Bloglines subscribers. One of the founders of the movement, medpundit, today has 58. Those numbers are one or two orders of magnitude shy of the readerships of many of the tech blogs I follow. But unless fear of malpractice strangles this baby in the cradle, that will be a temporary phenomenon. In the long run there will be many more people hungry for informed analysis of medical issues than for informed analysis of tech issues.

    This looks like a great opportunity to watch the blogging meme replicate throughout another community of practice. I’ll be fascinated to see how it changes, but also is changed by, that community. Corporate techbloggers, for example, are learning to walk a fine line between acceptable sharing of information and punishable transgression. Medbloggers face a different set of issues: libel, privacy, and of course malpractice. See this American Medical News article for a useful overview. [Jon Udell’s Weblog]

    As you can tell from some recent posts I’ve started following medical information on Pulmonary Fibrosis online, mostly inspired by this article. I even found a blog called Bronch Blog to subscribe to.

  • The Need For Patient Education

    One thing that amazes me is how much information is available on medical conditions and how few people ever find it. Hopefully things like this can help with that.

    Coalition for Pulmonary Fibrosis Announces Publication of New Educational Tools for Patients

    Preliminary Results From Latest Research Initiative Demonstrate Need for Lung
    Transplant and Pulmonary Rehabilitation Education for IPF Patients and
    Caregivers

    SAN JOSE, Calif., Sept. 17 /PRNewswire/ — The Coalition for Pulmonary
    Fibrosis
    (CPF) announced today the publication of two new educational
    brochures: ‘Lung Transplantation: What Every Patient with Idiopathic
    Pulmonary Fibrosis Should Know’ and ‘Oxygen Management and Pulmonary
    Rehabilitation for the IPF Patient’.

    The two brochures were created for patients, family members and physicians
    alike based on preliminary results of the CPF’s Basic Research Questionnaire,
    an education initiative launched last year to better understand the impact of
    idiopathic pulmonary fibrosis (IPF) on patients and families, and to help the
    foundation grasp the educational needs that arise for those fighting the
    disease.

    To date, the CPF has received more than 1,400 responses to this
    ground-breaking survey, and based on educational gaps identified by patients,
    discovered the need for improved education and awareness on two very important
    topics for IPF patients; lung transplantation and pulmonary rehabilitation.

    Interim results of the CPF’s research questionnaire found that among
    current patients, 30 percent responded that their physician has not discussed,
    or even mentioned the topic of lung transplantation, a potential treatment
    option for IPF patients under 65. Of those patients under the age of 60,
    fewer than half (47 percent) said they have been advised to seek a lung
    transplant. Additional data from a Duke University study also indicates that
    more than 50 percent of those with IPF who are on transplant lists will pass
    away before a donor lung becomes available. [via Feedster Search: Pulmonary Fibrosis]

    This also makes me very thankful that I found the doctors I did as I went through my diagnosis. I was quickly forwarded to a pulmonary specialist and he was able to give me a preliminary diagnosis almost immediately. Once it was confirmed that I did actually have Pulmonary Fibrosis we sat down and talked about what it all means, what treatments were available, how things tended to progress, what it meant long term, the whole thing. I still find it kind of stunning that other people have not had this same experience.

  • Possible New Treatments for Pulmonary Fibrosis

    I’ve started hunting for news items to do with Pulmonary Fibrosis in my news reader, so will be making note of interesting developments that I find.

    Treatment for pulmonary fibrosis may be achieved by blocking cell death in the lung

    A research team at Yale has found that blocking a kind of cell death called apoptosis in fibrotic diseases of the lung, also blocks the fibrosis, opening new ways of looking at treatment for lung diseases such as pulmonary fibrosis. [via Feedster Search: Pulmonary Fibrosis]